{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:15:46Z","timestamp":1789996546878,"version":"4.0.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2007,11,13]]},"DOI":"10.1007\/s00592-007-0007-6","type":"journal-article","created":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T02:57:12Z","timestamp":1188529032000},"page":"215-218","source":"Crossref","is-referenced-by-count":93,"title":["Effect of TNF-\u03b1 inhibition on urinary albumin excretion in experimental diabetic rats"],"prefix":"10.1007","volume":"44","author":[{"given":"Yuji","family":"Moriwaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asako","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneyoshi","family":"Ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenta","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumio","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,1]]},"reference":[{"key":"7_CR1","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ki.1991.308","volume":"40","author":"G Hasegawa","year":"1991","unstructured":"Hasegawa G, Nakano K, Sawada M et al (1991) Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40:1007\u20131012","journal-title":"Kidney Int"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000045634","volume":"85","author":"M Shikano","year":"2000","unstructured":"Shikano M, Sobajima H, Yoshikawa H et al (2000) Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 85:81\u201385","journal-title":"Nephron"},{"key":"7_CR3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/meta.2003.50096","volume":"52","author":"Y Moriwaki","year":"2003","unstructured":"Moriwaki Y, Yamamoto T, Shibutani Y et al (2003) Elevated levels of interleukin-18 and tumor necrosis factor-\u03b1 in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism 52:605\u2013608","journal-title":"Metabolism"},{"key":"7_CR4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1046\/j.1523-1755.2003.00237.x","volume":"64","author":"K Kalantarinia","year":"2003","unstructured":"Kalantarinia K, Awad AS, Siragy HM (2003) Urinary and renal interstitial concentrations of TNF-\u03b1 increase prior to the rise in albuminuria in diabetic rats. Kidney Int 64:1208\u20131213","journal-title":"Kidney Int"},{"key":"7_CR5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0272-6386(99)70182-4","volume":"33","author":"J Navarro","year":"1999","unstructured":"Navarro J, Mora C, Rivero A et al (1999) Urinary protein excretion and serum tumor necrosis factor alpha in diabetic patients with advanced renal failure: effects of pentoxifyline administration. Am J Kidney Dis 33:458\u2013463","journal-title":"Am J Kidney Dis"},{"key":"7_CR6","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1111\/j.1523-1755.2005.09918.x","volume":"99","author":"JF Navarro","year":"2005","unstructured":"Navarro JF, Milena FJ, Mora C et al (2005) Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition. Kidney Int Suppl 99:S98\u2013S102","journal-title":"Kidney Int Suppl"},{"key":"7_CR7","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W","volume":"41","author":"RN Maini","year":"1998","unstructured":"Maini RN, Breedveld FC, Kalden JR et al (1998) Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 41:1552\u20131563","journal-title":"Arthritis Rheum"},{"key":"7_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(99)70224-6","volume":"116","author":"FJ Baert","year":"1999","unstructured":"Baert FJ, D\u2019Haens GR, Peeters M et al (1999) Tumor necrosis factor alpha antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn\u2019s ileocolitis. Gastroenterology 116:22\u201328","journal-title":"Gastroenterology"},{"key":"7_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(96)00537-7","volume":"314","author":"N Yamamoto","year":"1996","unstructured":"Yamamoto N, Sakai F, Yamazaki H, Nakahara K, Okuhara M (1996) Effect of FR167653, a cytokine suppressive agent, on endotoxin-induced disseminated intravascular coagulation. Eur J Pharmacol 314:137\u2013142","journal-title":"Eur J Pharmacol"},{"key":"7_CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0014-2999(97)89657-4","volume":"327","author":"N Yamamoto","year":"1997","unstructured":"Yamamoto N, Sakai F, Yamazaki H, Sato N, Nakahara K, Okuhara M (1997) FR167653, a dual inhibitor of interleukin-1 and tumor necrosis factor-alpha, ameliorates endotoxin-induced shock. Eur J Pharmacol 327:169\u2013174","journal-title":"Eur J Pharmacol"},{"key":"7_CR11","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.lfs.2003.09.045","volume":"74","author":"T Ando","year":"2004","unstructured":"Ando T, Kurita S, Takamura T (2004) The specific p38 mitogen-activated protein kinase pathway inhibitor FR167653 keeps insulitis benign in nonobese diabetic mice. Life Sci 74:1817\u20131827","journal-title":"Life Sci"},{"key":"7_CR12","first-page":"1635","volume":"28","author":"K Olmarker","year":"2003","unstructured":"Olmarker K, Nutu M, Storkson R (2003) Changes in spontaneous behavior in rats exposed to experimental disc herniation are blocked by selective TNF-alpha inhibition. Spine 28:1635\u20131642","journal-title":"Spine"},{"key":"7_CR13","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1681\/ASN.2004121084","volume":"16","author":"M Koshikawa","year":"2005","unstructured":"Koshikawa M, Mukoyama M, Mori K et al (2005) Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. J Am Soc Nephrol 16:2690\u20132701","journal-title":"J Am Soc Nephrol"},{"key":"7_CR14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0171-2985(11)80356-6","volume":"187","author":"P Zabel","year":"1993","unstructured":"Zabel P, Schade FU, Schlaak M (1993) Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187:447\u2013463","journal-title":"Immunobiology"},{"key":"7_CR15","first-page":"116","volume":"43","author":"F Guerrero-Romero","year":"1995","unstructured":"Guerrero-Romero F, Rodriguez-Moran M, Paniagua-Sierra JR et al (1995) Pentoxifylline reduces proteinuria in insulin-dependent and non insulin-dependent diabetic patients. Clin Nephrol 43:116\u2013121","journal-title":"Clin Nephrol"},{"key":"7_CR16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s001250051241","volume":"42","author":"H Sugimoto","year":"1999","unstructured":"Sugimoto H, Shikata K, Wada J et al (1999) Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia 42:878\u2013886","journal-title":"Diabetologia"},{"key":"7_CR17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.2337\/diab.42.3.450","volume":"42","author":"T Nakamura","year":"1993","unstructured":"Nakamura T, Fukui M, Ebihara I et al (1993) mRNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450\u2013456","journal-title":"Diabetes"},{"key":"7_CR18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000079121","volume":"24","author":"K Dipetrillo","year":"2004","unstructured":"Dipetrillo K, Gesek FA (2004) Pentoxifylline ameliorates renal tumor necrosis factor expression, sodium retention, and renal hypertrophy in diabetic rats. Am J Nephrol 24:352\u2013359","journal-title":"Am J Nephrol"},{"key":"7_CR19","first-page":"83","volume":"24","author":"MA Gonzalez-Gay","year":"2006","unstructured":"Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C et al (2006) Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 24:83\u201386","journal-title":"Clin Exp Rheumatol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-007-0007-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-007-0007-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-007-0007-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T03:45:13Z","timestamp":1559101513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-007-0007-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,1]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,11,13]]}},"alternative-id":["7"],"URL":"https:\/\/doi.org\/10.1007\/s00592-007-0007-6","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,1]]}}}